Healthcare / Medical - SpecialtiesUpdated 2026-05-10 22:07 UTC

KOSDAQ/096530 stock hub

KOSDAQ/096530 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KOSDAQ/096530is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.1T

KOSDAQ

Market data

Live price

Current market quote for this ticker.

Current price

KOSDAQ/096530

In the news

Latest news · KOSDAQ/096530

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E28.7

P25 9.8P50 17.1P75 31.9

Trailing P/E23.3

P25 12P50 23.1P75 39.5

ROE4.8

P25 -17.1P50 0.7P75 8.5

ROIC5.2

P25 -9P50 1.3P75 6.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KOSDAQ/096530 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

235

Groups with data

Currency

KRW

Showing 235 of 235 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	216
Enterprise value	KRW 669.6B
Exchange	KOSDAQ
Financial currency	KRW
First seen	2026-05-10
Industry	Medical - Specialties
Isin	KR7096530001
Last refreshed	2026-05-10
Market cap	KRW 1.1T
Price	KRW 24,400
Price currency	KRW
Rev Per Employee	2,195,516,602.04x
Sector	Healthcare
Sic	2835
Symbol	kosdaq/096530
Website	https://www.seegene.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.29%
EV Earnings	13.87x
EV/EBIT	18.43x
EV/EBITDA	6.3x
EV/FCF	5.98x
EV/Sales	1.41x
FCF yield	9.95%
Forward P/E	28.74x
P/B ratio	1.11x
P/E ratio	23.31x
P/S ratio	2.37x
PE Ratio10 Y	119.5x
PE Ratio5 Y	135.51x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	7.28%
EBITDA Margin	22.05%
FCF margin	23.61%
Gross margin	64.08%
Gross Profit	KRW 303.9B
Gross Profit Growth	27.34%
Gross Profit Growth Q	50.9%
Gross Profit Growth3 Y	-15.07%
Gross Profit Growth5 Y	-18.74%
Net Income	KRW 48.3B
Net Income Growth Quarters	3%
Net Income Growth Years	1%
Net Income Growth3 Y	-35.76%
Net Income Growth5 Y	-37.4%
Pretax Margin	11.9%
Profit Margin	10.18%
Profit Per Employee	KRW 223.5M
Profitable Years	1
ROA	1.76
Roa5y	7.92
ROCE	3.24
ROE	4.82
Roe5y	16.5
ROIC	5.22
Roic5y	20.94

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	5.07%
Cagr15y	6.11%
Cagr1y	-3.53%
Cagr3y	3.29%
Cagr5y	-19.07%
Div CAGR3	11.2%
Div CAGR5	7.96%
EPS Growth Quarters	3
EPS Growth Years	1
EPS Growth3 Y	-33.67
EPS Growth5 Y	-35.89
FCF Growth	146.66%
FCF Growth3 Y	-24.07%
FCF Growth5 Y	-11.74%
OCF Growth	74.88%
OCF Growth Q	676.33%
OCF Growth3 Y	-22.35%
OCF Growth5 Y	-17.18%
Revenue Growth	14.48x
Revenue Growth Q	13.26x
Revenue Growth Quarters	8x
Revenue Growth Years	2x
Revenue Growth3 Y	-17.79x
Revenue Growth5 Y	-15.87x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.39
Assets	KRW 1.2T
Cash	KRW 585.9B
Current Assets	KRW 798.8B
Current Liabilities	KRW 170.8B
Debt	KRW 129.9B
Debt EBITDA	KRW 1.24
Debt Equity	KRW 0.13
Debt FCF	KRW 1.16
Equity	KRW 1T
Interest Coverage	7.73
Liabilities	KRW 220B
Long Term Assets	KRW 437B
Long Term Liabilities	KRW 49.2B
Net Cash	KRW 456B
Net Cash By Market Cap	KRW 40.52
Net Cash Growth	21.08%
Net Debt EBITDA	KRW -4.36
Net Debt Equity	KRW -0.45
Net Debt FCF	KRW -4.07
Tangible Book Value	KRW 986.8B
Tangible Book Value Per Share	KRW 21,400
WACC	7.9

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.68
Inventory Turnover	1.78
Net Working Capital	KRW 137.6B
Quick ratio	4.01
Working Capital	KRW 628B
Working Capital Turnover	KRW 0.77

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.08%
Dividend Growth	37.5%
Dividend Growth Years	1%
Dividend per share	KRW 800
Dividend Years	8
Dividend Yield	3.28%
Ex Div Date	2026-03-30
Last Dividend	KRW 300
Payout Frequency	Quarterly
Payout Ratio	76.44%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	63.93%
1Y total return	-3.53%
200-day SMA	25,611.8
3Y total return	10.21%
50-day SMA	23,652
50-day SMA vs 200-day SMA	50under200
5Y total return	-65.27%
All Time High	161,100
All Time High Change	-84.85%
All Time High Date	2020-08-10
All Time Low	3,140
All Time Low Change	677.07%
All Time Low Date	2010-09-10
ATR	904.7
Beta	0.77
Beta1y	0.96
Beta2y	0.55
Ch YTD	2.52
High	25,050
High52	36,650
High52 Date	2025-05-22
High52ch	-33.42%
Low	24,100
Low52	21,700
Low52 Date	2026-03-09
Low52ch	12.44%
Ma50ch	3.16%
Price vs 200-day SMA	-4.73%
RSI	51.14
RSI Monthly	47.08
RSI Weekly	47.85
Sharpe ratio	0.12x
Sortino ratio	0.32
Total Return	3.36%
Tr YTD	3.41
Tr15y	143.4%
Tr1m	9.66%
Tr1w	-0.41%
Tr3m	-4.79%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW 34.5B
Operating Income Growth3 Y	-42.41
Operating Income Growth5 Y	-44.83
Operating margin	7.28

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	31,072,320%
Net Borrowing	-22,978,086,780
Shares Insiders	31.67%
Shares Institutions	6.24%
Shares Out	46,114,611
Shares Qo Q	0%
Shares Yo Y	-0.08%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW 111.2B
Average Volume	333,265.8x
Bv Per Share	22,020.1
CAPEX	KRW -37.4B
Ch10y	38.64
Ch15y	105.8
Ch1m	9.66
Ch1w	-0.41
Ch1y	-7.22
Ch3m	-5.61
Ch3y	-1.21
Ch5y	-70.28
Ch6m	-4.13
Change	1.67%
Change From Open	-1.21
Close	24,000
Days Gap	2.92
Depreciation Amortization	70,008,597,000
Dollar Volume	7,341,472,000
Earnings Date	2026-05-08
EBIT	KRW 34.5B
EBITDA	KRW 104.6B
EPS	KRW 1,047
F Score	7
FCF	KRW 112B
FCF EV Yield	16.72x
FCF Per Share	KRW 2,428
Financing CF	-64,005,835,220
Fiscal Year End	December
Founded	2,000
Goodwill	9,001,044,000
Graham Number	22772.75753
Graham Upside	-6.67
Income Tax	KRW 8B
Investing CF	-133,172,552,870
Is Primary Listing	1
Last Earnings Date	2026-05-08
Last Report Date	2025-12-31
Last Split Date	2021-04-23
Last Split Type	Forward
Lynch Fair Value	KRW 5,234
Lynch Upside	-78.55
Ma150	24,822
Ma150ch	-1.7%
Ma20	24,627.5
Ma20ch	-0.92%
Net CF	-34,125,308,860
Next Earnings Date	2026-08-07
Open	24,700
P FCF Ratio	10.05
P OCF Ratio	7.53
Payment Date	2026-05-15
Position In Range	31.58
Ppne	270,015,373,210
Price Date	2026-05-08
Price EBITDA	KRW 10.76
Ptbv Ratio	1.14
Relative Volume	0.92x
Revenue	474,231,586,040x
SBC By Revenue	0.16x
Share Based Comp	768,132,000
Tax By Revenue	1.68x
Tax Rate	14.16%
Tr6m	-1.68%
Volume	300,880
Z Score	5.69

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

KOSDAQ/096530 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.3%

$800 annual per share

Payout ratio

+76.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+8.0%

1 consecutive years of growth

Total shareholder yield

+3.4%

Next ex-dividend date: 2026-03-30

Performance

KOSDAQ/096530 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KOSDAQ/096530?

Insider, institutional, and short-interest positioning.

Institutional ownership

+6.2%

Share of float held by funds and institutions

Insider ownership

+31.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.1%

Negative means the company is buying back shares.

Technical

KOSDAQ/096530 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.1

Neutral momentum band

Price vs 200-day MA

-4.7%

50/200-day relationship not available

Beta (5Y)

0.77

Less volatile than the market

Sharpe ratio

0.12

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KOSDAQ/096530

Hub-level FAQ points readers to the deeper analysis pages.

What is the current kosdaq/096530 stock rating?

kosdaq/096530 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full kosdaq/096530 analysis?

The full report lives at /stocks/kosdaq/096530/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for kosdaq/096530?

The latest report frames kosdaq/096530 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the kosdaq/096530 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.